-
1 Comment
China Medical System Holdings Limited is currently in a long term uptrend where the price is trading 30.8% above its 200 day moving average.
From a valuation standpoint, the stock is 99.6% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 4.8.
Finally, its free cash flow grew by 3.4% to $616M since the same quarter in the previous year.
Based on the above factors, China Medical System Holdings Limited gets an overall score of 3/5.
Exchange | F |
---|---|
CurrencyCode | EUR |
ISIN | KYG211081248 |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Market Cap | 2B |
---|---|
PE Ratio | 11.81 |
Target Price | None |
Dividend Yield | 3.5% |
Beta | 0.91 |
China Medical System Holdings Limited is an investment holding company that manufactures, sells, markets, and promotes pharmaceutical products in the People's Republic of China, covering areas such as cardio-cerebrovascular, gastroenterology, dermatology, medical aesthetics, and ophthalmology. Its cardio-cerebrovascular products include VELPHORO sucroferric oxyhydroxide chewable tablets, diazepam nasal spray for seizure clusters, XinHuoSu recombinant human brain natriuretic peptide for acute heart failure, Plendil for hypertension, Deanxit for mild-to-moderate depression, and Imdur for coronary heart disease. The gastroenterology line features METOJECT for psoriasis and rheumatoid arthritis, LUMEBLUE for colorectal lesion visualization, Salofalk for ulcerative colitis and Crohn's disease, Bioflor for diarrhea, Combizym for digestive issues, Cidine for dyspepsia symptoms, and Ursofalk for cholesterol gallstones. In dermatology, it offers ILUMETRI for plaque psoriasis, Aethoxysklerol for varicose veins, and Hirudoid Azelaic Acid for acne care, alongside dermatology-grade products like Heling Soothing. The light medical aesthetic line includes Vmonalisa Hyaluronate Filler, while the ophthalmology line features Augentropfen Stulln Mono Eye Drops and EyeOP1 Glaucoma Treatment Device. Further, its other products include Elcitonin, Yinuoshu, Xidakang, Parlodel, DanShenTong, and Vmonalisa. The company was founded in 1995 and is headquartered in North Point, Hong Kong. China Medical System Holdings Limited is a subsidiary of Treasure Sea Limited.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 2M7C.F using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025